v3.25.3
Intangibles, Net and Goodwill (Tables)
 9 Months Ended
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Rollforward of Intangible Assets A rollforward of the Company's intangible assets for the nine months ended September 30, 2025 and 2024 is as follows (in thousands):
Intangible AssetDecember 31, 2024AdditionsAmortizationSeptember 30, 2025
Acquired ARIKAYCE R&D$27,888 $— $(3,638)$24,250 
PARI milestones1,164 — (151)1,013 
AstraZeneca milestone— 30,000 (275)29,725 
Acquired IPR&D29,600 — — 29,600 
$58,652 $30,000 $(4,064)$84,588 
Intangible AssetDecember 31, 2023AdditionsAmortizationSeptember 30, 2024
Acquired ARIKAYCE R&D$32,738 $— $(3,638)$29,100 
PARI milestones1,366 — (151)1,215 
Acquired IPR&D29,600 — — 29,600 
$63,704 $— $(3,789)$59,915